14
Views
5
CrossRef citations to date
0
Altmetric
Original Article

HISTOPATHOLOGICAL CHANGES IN EXOCRINE GLANDS OF MURINE TRANSPLANTATION CHIMERAS. II: SJOGREN'S SYNDROME-LIKE EXOCRINOPATHY IN MICE WITHOUT LUPUS NEPHRITIS. A MODEL OF PRIMARY SJOGREN'S SYNDROME

, , , &
Pages 273-280 | Received 24 Oct 1991, Published online: 07 Jul 2009
 

Abstract

Autoimmune reactions are evoked in hybrid mice after induction of a chronic graft-versus-host reaction by transfer of viable leucocytes from one of the parental strains to non-irradiated F, recipients. We have previously demonstrated an SLE-like syndrome early in the reaction, with an additional Sjogren's syndrome-like glandular affection occurring later.

In this study, we used Balb/c mice as donors and Balb/cxCBA/H-T6 F, hybrids as recipients. We found serum autoantibodies characteristic of SLE after 9 weeks but not after 20 weeks. No clinical signs of disease were seen at any time. After prolonged studies (5 months), we found heavy inflammation in Harderian. salivary, and tear glands. All animals survived the entire length of the experiment without signs of renal failure. The pathological manifestations: lymphocytic infiltration of exocrine glands, and enlargement of lymph nodes, are similar to those seen in patients with Sjogren's syndrome. This murine transplantation chimera may be a useful experimental model lor primary Sjogren's syndrome.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.